You are here
Global Microfluidics Market Forecasts, 2019 to 2024 - Leading Players are Danaher Corporation, PerkinElmer, Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific
DUBLIN, March 21, 2019 /PRNewswire/ -- The "Microfluidics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
The global microfluidics market was valued at USD 4,748.18 million in 2018, and is estimated to be valued at USD 13,348.29 million in 2024, witnessing a CAGR of 18.8%.
Factors that are propelling the growth of the market include rising demand for point-of-care testing, increasing Incidences of chronic diseases, faster turn-around time for analysis, and improved portability of devices.
POC testing allows healthcare experts to diagnose a patient in the physician's office, in an ambulance, at home, field, or in the hospital. Microfluidic technology-assisted devices are being employed for POC testing, as they require small volumes of samples and use micro-fabricated channels to analyze these samples. POC testing devices are already popular in glucose, blood, hemoglobin, and HIV testing domains. Future POC testing devices are likely to focus more on antibiotics therapies and cancer.
With the wide range of applications offered by these devices, microfluidic technology-based POC testing devices have immense potential in the developing and developed countries, as the percentage of population affected by these diseases is high.
Key Market Trends
Clinical Diagnostics is Expected to hold its Highest Market Share in the Application Segment
In the application segment of the microfluidics market, clinical diagnostics is believed to have the largest market size and is expected to witness a CAGR of 18.8% during the forecast period.
A significant application area for microfluidic technology is clinical diagnostics. Specifically for clinical diagnostics, diseases, including toxicity, can be diagnosed by performing various biochemical analyzes and by observation of symptoms. The biochemical changes in the patient's blood can signal organ damage or dysfunction, prior to observable microscopic cellular damages or other symptoms.
So there has been a large demand for the development of an easy-to-handle and inexpensive clinical diagnostic biochip using fully integrated plastic microfluidic chips, which have the sampling/identifying capability of fast and reliable measurements of metabolic parameters from a human body with minimum invasion. Thus, the growth of clinical diagnostics is expected to fuel the market's growth.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
The North American region holds the largest market share in the market for microfluidics. This is attributed to factors, such as the well-established healthcare system, along with better reimbursement policies, and the higher adoption of novel therapeutics among the general population. Microfluidics is a vastly growing field in the United States, in terms of high budget sanctions for R&D.
Molecular diagnostics and point-of-care diagnostics widely use microfluidic technology for various applications, and hence, they occupy a major market share in the United States. Owing to this, the United States has the largest market share of 88% in North America, and is expected to grow at a rate of 18.8% over the forecast period.
The microfluidics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with affordable prices.
Companies, like Danaher Corporation, PerkinElmer, Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific, hold substantial shares in the market.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Point-of-care Testing
4.2.2 Increasing Incidences of Chronic Diseases
4.2.3 Faster Turn-around Time for Analysis and Improved Portability of Devices
4.3 Market Restraints
4.3.1 Need for Specialized Skills in Operations and Complex Regulatory Approval Process
4.3.2 Low Adoption in Developing Countries due to High Prices
4.4 Porter's Five Forces Analysis
5 Market Segmentation
5.1.1 Microfluidic Chips
5.1.2 Micro Pumps
5.1.3 Micro Needles
5.1.4 Other Components
5.2.1 Drug Delivery
5.2.2 High-throughput Screening
5.2.3 Point-of-Care Diagnostics
5.2.4 Lab Analytics
18.104.22.168 Cell-based Assay
22.214.171.124 Capillary Electrophoresis
5.2.5 Clinical Diagnostics
5.4.1 North America
5.4.4 Middle East & Africa
5.4.5 South America
6 Competitive Landscape
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 F. Hoffmann-La Roche Ltd.
6.1.3 Agilent Technologies
6.1.4 Danaher Corporation (Cepheid)
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 Bio-Rad Laboratories Inc.
6.1.7 PerkinElmer Inc.
6.1.8 FluIdigm Corporation
6.1.9 Dolomite Microfluidics (Blacktrace Holdings Ltd.)
6.1.10 Micronit Microfluidics
7 Market Opportunities and Future Trends
For more information about this report visit
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-microfluidics-market-forecasts-2019-to-2024---leading-players-are-danaher-corporation-perkinelmer-agilent-technologies-bio-rad-laboratories-and-thermo-fisher-scientific-300815844.html
SOURCE Research and Markets